BNP Paribas Financial Markets’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33M | Buy |
137,057
+121,263
| +768% | +$26.6M | 0.01% | 986 |
|
|
2026
Q1 | $2.99M | Buy |
15,794
+3,747
| +31% | +$655K | ﹤0.01% | 2412 |
|
|
2025
Q4 | $2.05M | Sell |
12,047
-76,517
| -86% | -$11.7M | ﹤0.01% | 2602 |
|
|
2025
Q3 | $11.7M | Buy |
88,564
+61,075
| +222% | +$7.33M | 0.01% | 1440 |
|
|
2025
Q2 | $2.92M | Buy |
27,489
+10,124
| +58% | +$1.1M | ﹤0.01% | 2210 |
|
|
2025
Q1 | $2.16M | Sell |
17,365
-745
| -4% | -$97.2K | ﹤0.01% | 2322 |
|
|
2024
Q4 | $2.23M | Buy |
18,110
+1,277
| +8% | +$151K | ﹤0.01% | 2306 |
|
|
2024
Q3 | $1.88M | Buy |
16,833
+7,815
| +87% | +$856K | ﹤0.01% | 2087 |
|
|
2024
Q2 | $962K | Sell |
9,018
-64,511
| -88% | -$7.09M | ﹤0.01% | 2296 |
|
|
2024
Q1 | $8.85M | Sell |
73,529
-7,024
| -9% | -$860K | 0.01% | 1136 |
|
|
2023
Q4 | $9.91M | Buy |
80,553
+65,685
| +442% | +$8.2M | 0.01% | 1032 |
|
|
2023
Q3 | $1.92M | Buy |
14,868
+225
| +2% | +$30K | ﹤0.01% | 1901 |
|
|
2023
Q2 | $1.82M | Sell |
14,643
-5,682
| -28% | -$764K | ﹤0.01% | 1812 |
|
|
2023
Q1 | $2.97M | Sell |
20,325
-50,665
| -71% | -$7.49M | ﹤0.01% | 1558 |
|
|
2022
Q4 | $11.3M | Buy |
+70,990
| New | +$10.4M | 0.02% | 913 |
|
|
2022
Q3 | – | Sell |
-15,947
| Closed | -$2.49M | – | 4882 |
|
|
2022
Q2 | $2.49M | Sell |
15,947
-8,781
| -36% | -$1.35M | ﹤0.01% | 1627 |
|
|
2022
Q1 | $3.85M | Buy |
24,728
+2,668
| +12% | +$387K | 0.01% | 1434 |
|
|
2021
Q4 | $2.81M | Sell |
22,060
-4,700
| -18% | -$618K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $3.48M | Sell |
26,760
-65,703
| -71% | -$9.93M | ﹤0.01% | 1520 |
|
|
2021
Q2 | $16.4M | Sell |
92,463
-245,110
| -73% | -$42.5M | 0.02% | 723 |
|
|
2021
Q1 | $55.5M | Buy |
337,573
+286,319
| +559% | +$47.1M | 0.08% | 264 |
|
|
2020
Q4 | $8.46M | Buy |
51,254
+31,160
| +155% | +$4.64M | 0.02% | 879 |
|
|
2020
Q3 | $2.87M | Sell |
20,094
-40,369
| -67% | -$5M | ﹤0.01% | 1335 |
|
|
2020
Q2 | $6.67M | Sell |
60,463
-179,834
| -75% | -$19.9M | 0.01% | 905 |
|
|
2020
Q1 | $24M | Buy |
240,297
+152,827
| +175% | +$19.8M | 0.05% | 342 |
|
|
2019
Q4 | $13.1M | Sell |
87,470
-80,414
| -48% | -$10.9M | 0.02% | 687 |
|
|
2019
Q3 | $21.5M | Buy |
167,884
+43,268
| +35% | +$5.8M | 0.04% | 468 |
|
|
2019
Q2 | $17.8M | Sell |
124,616
-223,875
| -64% | -$30.1M | 0.04% | 490 |
|
|
2019
Q1 | $49.8M | Buy |
348,491
+322,112
| +1,221% | +$42M | 0.11% | 204 |
|
|
2018
Q4 | $3.27M | Sell |
26,379
-113,383
| -81% | -$16.8M | 0.01% | 1098 |
|
|
2018
Q3 | $23.5M | Buy |
139,762
+76,638
| +121% | +$13.2M | 0.03% | 478 |
|
|
2018
Q2 | $10.9M | Buy |
63,124
+31,847
| +102% | +$5.21M | 0.02% | 770 |
|
|
2018
Q1 | $4.72M | Buy |
31,277
+16,776
| +116% | +$2.46M | 0.01% | 1022 |
|
|
2017
Q4 | $1.95M | Sell |
14,501
-226
| -2% | -$31.3K | ﹤0.01% | 1493 |
|
|
2017
Q3 | $2.15M | Buy |
14,727
+2,117
| +17% | +$320K | 0.01% | 1100 |
|
|
2017
Q2 | $1.96M | Buy |
12,610
+642
| +5% | +$98.2K | 0.01% | 1193 |
|
|
2017
Q1 | $1.74M | Sell |
11,968
-14,690
| -55% | -$1.91M | ﹤0.01% | 1123 |
|
|
2016
Q4 | $2.91M | Buy |
26,658
+17,186
| +181% | +$1.91M | 0.01% | 778 |
|
|
2016
Q3 | $1.15M | Buy |
9,472
+3,548
| +60% | +$478K | ﹤0.01% | 883 |
|
|
2016
Q2 | $837K | Sell |
5,924
-28,353
| -83% | -$4.18M | ﹤0.01% | 1262 |
|
|
2016
Q1 | $4.47M | Sell |
34,277
-10,893
| -24% | -$1.36M | 0.02% | 603 |
|
|
2015
Q4 | $6.35M | Buy |
45,170
+6,751
| +18% | +$936K | 0.02% | 566 |
|
|
2015
Q3 | $5.1M | Buy |
38,419
+6,434
| +20% | +$1.11M | 0.01% | 637 |
|
|
2015
Q2 | $5.63M | Buy |
31,985
+27,785
| +662% | +$4.99M | 0.02% | 557 |
|
|
2015
Q1 | $726K | Sell |
4,200
-5,715
| -58% | -$981K | ﹤0.01% | 1197 |
|
|
2014
Q4 | $1.62M | Sell |
9,915
-26,511
| -73% | -$4.4M | 0.01% | 865 |
|
|
2014
Q3 | $5.85M | Buy |
36,426
+92
| +0.3% | +$14.1K | 0.01% | 677 |
|
|
2014
Q2 | $5.34M | Buy |
36,334
+7,512
| +26% | +$1.04M | 0.01% | 637 |
|
|
2014
Q1 | $3.89M | Buy |
28,822
+5,802
| +25% | +$873K | ﹤0.01% | 729 |
|
|
2013
Q4 | $2.91M | Buy |
23,020
+11,654
| +103% | +$1.21M | ﹤0.01% | 789 |
|
|
2013
Q3 | $1.05M | Buy |
11,366
+450
| +4% | +$36.3K | ﹤0.01% | 1120 |
|
|
2013
Q2 | $750K | Buy |
+10,916
| New | +$667K | ﹤0.01% | 1215 |
|
Other funds holding JAZZ
BNP Paribas Financial Markets's JAZZ Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Jazz Pharmaceuticals (JAZZ) stake by 768% in Q2 2026, buying an estimated $26.6M and bringing the position to 137,057 shares worth $33M. The position accounts for 0.01% of the portfolio, ranked #986.
BNP Paribas Financial Markets first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.5M in Q1 2021. 602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- BNP Paribas Financial Markets held 137,057 shares of Jazz Pharmaceuticals worth $33M as of Q2 2026.
- BNP Paribas Financial Markets bought 121,263 Jazz Pharmaceuticals shares in Q2 2026, an estimated $26.6M.
- Jazz Pharmaceuticals made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #986 holding.
- BNP Paribas Financial Markets first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Jazz Pharmaceuticals position peaked at $55.5M in Q1 2021.
- 602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.